Targeting tumour vasculature: the development of combretastatin A4

The Lancet Oncology
Jeremy GriggsRobin Hesketh

Abstract

The requirement for neovascularisation to permit the development of solid tumours beyond a threshold size, has focused attention on the therapeutic potential of agents that prevent angiogenesis. The multistep nature of angiogenesis presents several targets for intervention, including the inhibition of the endothelial-cell migration or proliferation normally associated with developing vessels. Compounds that damage established tumour vasculature are also of potential clinical use. We review the development of one such antivascular drug, combretastatin A4. This tubulin-binding agent was originally isolated from an African shrub, Combretum caffrum. The disodium combretastatin A4 phosphate prodrug is currently undergoing phase I clinical trials in the UK and USA. This review assesses the in vitro and in vivo data for combretastatin and the prodrug, and the preliminary data that have emerged from the phase I clinical trials.

References

Dec 16, 1992·Journal of the National Cancer Institute·N WeidnerG Gasparini
Apr 17, 1997·Nature·W Risau
May 30, 1998·Journal of Medicinal Chemistry·G R PettitR K Pettit
Dec 9, 1998·International Journal of Radiation Oncology, Biology, Physics·M R HorsmanJ Overgaard
Dec 9, 1998·International Journal of Radiation Oncology, Biology, Physics·L LiD W Siemann
Feb 10, 2000·The American Journal of Pathology·R FolbergA J Maniotis
Feb 10, 2000·The American Journal of Pathology·D M McDonaldR K Jain
Mar 4, 2000·International Journal of Radiation Oncology, Biology, Physics·H P EikesdalO Dahl
Jun 1, 1951·British Journal of Pharmacology and Chemotherapy·S E DICKER

❮ Previous
Next ❯

Citations

Jul 7, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·A M Gaya, G J S Rustin
Jun 1, 2005·European Journal of Pharmacology·Beatriz Martínez-PovedaMiguel Angel Medina
Nov 30, 2002·Trends in Pharmacological Sciences·Andreas Bikfalvi, Roy Bicknell
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·R Barbara PedleyRichard H J Begent
Mar 8, 2003·The Lancet Oncology·Bruce C Baguley
Dec 2, 2006·Nature Clinical Practice. Oncology·Matthew M CooneyScot C Remick
Mar 15, 2003·Nature Reviews. Cancer·John Mann
Oct 5, 2010·Nature Reviews. Drug Discovery·Charles Dumontet, Mary Ann Jordan
Feb 21, 2003·Thyroid : Official Journal of the American Thyroid Association·Joshua M DzibaKenneth B Ain
May 22, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Li MaQiang Zhang
Dec 17, 2010·Molecular Cancer Therapeutics·Sarah E BohndiekKevin M Brindle
Aug 31, 2010·Future Oncology·Govardhanan Nagaiah, Scot C Remick
Jun 1, 2013·Thyroid : Official Journal of the American Thyroid Association·Julie A SosaScot C Remick
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Samu MelkkoDario Neri
Jan 20, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H WildiersA T van Oosterom
Jul 6, 2014·BMC Complementary and Alternative Medicine·Rejoice MoyoStanley Mukanganyama
Mar 16, 2007·Bioorganic & Medicinal Chemistry·Daniel J KerrBernard L Flynn
May 7, 2014·Chemical Biology & Drug Design·Jing GuoYong-Hua Yang
Mar 14, 2002·The American Journal of Pathology·Jeremy GriggsRobin Hesketh
May 16, 2006·Trends in Pharmacological Sciences·Tai-Ping FanRicky N S Wong
Oct 21, 2015·Analytical Cellular Pathology (Amsterdam)·Daniele FanaleViviana Bazan
May 20, 2015·Veterinary and Comparative Oncology·E AbmaH de Rooster
May 2, 2008·Expert Opinion on Investigational Drugs·Robert O Carlson
Mar 6, 2013·The Journal of Steroid Biochemistry and Molecular Biology·Swati PariharArvind S Negi
Jun 29, 2004·Biochemical and Biophysical Research Communications·Casimiro CárdenasMiguel Angel Medina
Jan 13, 2016·Journal of Evidence-based Complementary & Alternative Medicine·Mahmood BahmaniMahmoud Rafieian-Kopaei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinosarcoma

Carcinosarcoma is a malignant neoplasm that contains elements of carcinoma and sarcoma so extensively intermixed as to indicate neoplasia of epithelial and mesenchymal tissue. Discover the latest research on carcinosarcoma here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Related Papers

Natural Product Reports
Alessandra Cirla, John Mann
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
G J S RustinPatricia M Price
Expert Opinion on Investigational Drugs
Scott L Young, David J Chaplin
International Journal of Experimental Pathology
Gillian M TozerSally A Hill
© 2022 Meta ULC. All rights reserved